Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

5.8%

3 terminated/withdrawn out of 52 trials

Success Rate

94.1%

+7.6% vs industry average

Late-Stage Pipeline

38%

20 trials in Phase 3/4

Results Transparency

63%

30 of 48 completed trials have results

Key Signals

30 with results

Enrollment Performance

Analytics

Phase 3

17(41.5%)

Phase 1

10(24.4%)

Phase 2

8(19.5%)

Phase 4

3(7.3%)

N/A

2(4.9%)

Early Phase 1

1(2.4%)

41Total

Phase 3(17)

Phase 1(10)

Phase 2(8)

Phase 4(3)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials

NCT05630872Phase 2Completed

Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis

Role: collaborator

NCT05051527Completed

Study to Evaluate the Effectiveness of Legalon®

Role: lead

NCT05139121Phase 3Completed

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Role: collaborator

NCT05637515Phase 3Completed

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Role: collaborator

NCT05158972Completed

Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients

Role: lead

NCT05000541Completed

Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical

Role: lead

NCT04976868Completed

Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

Role: lead

NCT02094716Phase 2Completed

A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies

Role: lead

NCT00634166Phase 4Terminated

Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group

Role: lead

NCT04571515Phase 2Completed

Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain

Role: lead

NCT02921763Completed

A Survey on Efficacy and Safety in Patients With Endometriosis

Role: lead

NCT01427725Completed

Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

Role: lead

NCT01427712Completed

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Role: lead

NCT01097005Completed

Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections

Role: lead

NCT02579122Terminated

REVIparin-BRIDging-in a General Practice Setting in GErmany

Role: lead

NCT01632878Completed

Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study

Role: lead

NCT05030025Early Phase 1Completed

Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg)

Role: lead

NCT02469987Phase 1Completed

Phase I - Pharmacokinetic Comparability Study in Healthy Male Volunteers

Role: lead

NCT02449031Completed

Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs

Role: lead

NCT02104180Not ApplicableCompleted

Evaluation of Pain Associated With the Removal of Wound Dressing During Care of Venous Leg Ulcer. Comparison of the Efficacy and Safety of Two Dressings Urgotul and TulleGras

Role: lead